Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report) traded down 6.6% during trading on Friday . The stock traded as low as $15.37 and last traded at $15.37. 2,797 shares were traded during trading, a decline of 83% from the average session volume of 16,252 shares. The stock had previously closed at $16.46.
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on TLX shares. UBS Group began coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Friday, November 15th. They issued a "buy" rating and a $21.00 price objective on the stock. William Blair upgraded Telix Pharmaceuticals Limited American Depositary Shares to a "strong-buy" rating in a research note on Tuesday, November 19th.
Check Out Our Latest Analysis on Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Limited American Depositary Shares Price Performance
About Telix Pharmaceuticals Limited American Depositary Shares
(
Get Free Report)
Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.
Featured Articles
Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.
While Telix Pharmaceuticals Limited American Depositary Shares currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
